EpiCept Reports New Data On Benefits Of Maintenance Therapy With Ceplene(R) And Interleukin-2 For AML Patients At ASH Annual Meeting

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that new data on the benefits of maintenance therapy with Ceplene� (histamine dihydrochloride) and interleukin-2 (IL-2) for Acute Myeloid Leukemia (AML) patients in complete remission will be presented at the 50th American Society of Hematology (ASH) Annual Meeting being held December 6-9 at the Moscone Center in San Francisco.

More: continued here

Filed under: Blood on December 4th, 2008

Comments are closed.

« BioMarin Uses Itamar Medical’s Endo-PAT2000 In Successful Phase 2 Study For New Treatment For Sickle Cell Disease New York Times Examines British Cost-Effective Treatment System; Could Become Model For U.S. »

My Pills Store - Buy Online: My Pills store
Order RX Drugs - Buy Online: Order RX Drugs from pharmacy online.
Order pills online - : Order pills online
Pills 2 Me - Order RX Pills for You: Just select the medicines you need, fill in our medical questionnaire, and submit your order.
RX Hint - Information and products: Find more details about Rx products only by entering.
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Your Health Rx - : Your Health Rx
Latest News...